Phenolic Compounds of <i>Rhodiola rosea</i> L. as the Potential Alternative Therapy in the Treatment of Chronic Diseases
2023
Jurga Bernatoniene | Valdas Jakstas | Dalia M. Kopustinskiene
The roots and rhizomes of <i>Rhodiola rosea</i> L. (Crassulaceae), which is widely growing in Northern Europe, North America, and Siberia, have been used since ancient times to alleviate stress, fatigue, and mental and physical disorders. Phenolic compounds: phenylpropanoids rosavin, rosarin, and rosin, tyrosol glucoside salidroside, and tyrosol, are responsible for the biological action of <i>R. rosea</i>, exerting antioxidant, immunomodulatory, anti-aging, anti-fatigue activities. <i>R. rosea</i> extract formulations are used as alternative remedies to enhance mental and cognitive functions and protect the central nervous system and heart during stress. Recent studies indicate that <i>R. rosea</i> may be used to treat diabetes, cancer, and a variety of cardiovascular and neurological disorders such as Alzheimer’s and Parkinson’s diseases. This paper reviews the beneficial effects of the extract of <i>R. rosea</i>, its key active components, and their possible use in the treatment of chronic diseases. <i>R. rosea</i> represents an excellent natural remedy to address situations involving decreased performance, such as fatigue and a sense of weakness, particularly in the context of chronic diseases. Given the significance of mitochondria in cellular energy metabolism and their vulnerability to reactive oxygen species, future research should prioritize investigating the potential effects of <i>R. rosea</i> main bioactive phenolic compounds on mitochondria, thus targeting cellular energy supply and countering oxidative stress-related effects.
Afficher plus [+] Moins [-]Mots clés AGROVOC
Informations bibliographiques
Cette notice bibliographique a été fournie par Directory of Open Access Journals
Découvrez la collection de ce fournisseur de données dans AGRIS
